Our findings suggest the possible clinical utility of the QFT-Plus assay CD8+ response to indicate M. tb activity in hosts who may not have clear-cut signs and symptoms, to provide guidance on whether to investigate and/or to treat as for TB disease. Here, CD8A is linked to tuberculosis.